Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Welsch

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|May 25, 1990
Partial purification and characterization of bovine liver aspartyl beta-hydroxylaseR S Gronke, D J Welsch, W J VanDusen, et al.
Science (New York, N.Y.)|June 16, 1989
Regulation of chloride channels by protein kinase C in normal and cystic fibrosis airway epitheliaM Li, J D McCann, M P Anderson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
Novel, selective delta6 or delta5 fatty acid desaturase inhibitors as antiinflammatory agents in miceM G Obukowicz, D J Welsch, W J Salsgiver, et al.
Molecular Endocrinology (Baltimore, Md.)|March 12, 2005
The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanismsMonica L Hultman, Nataliia V Krasnoperova, Suzhen Li, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 26, 2006
Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson's diseaseS Happe, T Tings, W Koch, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 2021
Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary FibrosisRobert N Willette, Parth Mangrolia, Stephen M Pondell, et al.
The Journal of Biological Chemistry|July 15, 1990
Molecular defect (Gla+14----Lys) and its functional consequences in a hereditary factor X deficiency (factor X "Vorarlberg")H H Watzke, K Lechner, H R Roberts, et al.
Thrombosis and Haemostasis|July 6, 1992
Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cellsT C Wun, K K Kretzmer, M O Palmier, et al.
Osteoarthritis and Cartilage|June 7, 2006
Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritisM-P Hellio Le Graverand, K D Brandt, S A Mazzuca, et al.
Protein Expression and Purification|June 1, 1994
Renaturation and purification of human tissue factor pathway inhibitor expressed in recombinant E. coliM E Gustafson, K D Junger, T C Wun, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|May 25, 1990
Partial purification and characterization of bovine liver aspartyl beta-hydroxylaseR S Gronke, D J Welsch, W J VanDusen, et al.
Science (New York, N.Y.)|June 16, 1989
Regulation of chloride channels by protein kinase C in normal and cystic fibrosis airway epitheliaM Li, J D McCann, M P Anderson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
Novel, selective delta6 or delta5 fatty acid desaturase inhibitors as antiinflammatory agents in miceM G Obukowicz, D J Welsch, W J Salsgiver, et al.
Molecular Endocrinology (Baltimore, Md.)|March 12, 2005
The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanismsMonica L Hultman, Nataliia V Krasnoperova, Suzhen Li, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 26, 2006
Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson's diseaseS Happe, T Tings, W Koch, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 2021
Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary FibrosisRobert N Willette, Parth Mangrolia, Stephen M Pondell, et al.
The Journal of Biological Chemistry|July 15, 1990
Molecular defect (Gla+14----Lys) and its functional consequences in a hereditary factor X deficiency (factor X "Vorarlberg")H H Watzke, K Lechner, H R Roberts, et al.
Thrombosis and Haemostasis|July 6, 1992
Comparison of recombinant tissue factor pathway inhibitors expressed in human SK hepatoma, mouse C127, baby hamster kidney, and Chinese hamster ovary cellsT C Wun, K K Kretzmer, M O Palmier, et al.
Osteoarthritis and Cartilage|June 7, 2006
Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritisM-P Hellio Le Graverand, K D Brandt, S A Mazzuca, et al.
Protein Expression and Purification|June 1, 1994
Renaturation and purification of human tissue factor pathway inhibitor expressed in recombinant E. coliM E Gustafson, K D Junger, T C Wun, et al.
Pageof 5